> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Cross Labeling Oncology Drugs Guidance
- URL: https://www.fdaweb.com/cross-labeling-oncology-drugs-guidance/
- Published: 2020-11-20T12:00:00.000Z
- Updated: 2026-09-14T16:37:24.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148136

*Federal Register* notice: FDA is announcing the availability of a draft guidance for industry entitled *Cross Labeling Oncology Drugs in Combination Drug Regimens.* The document describes the agency’s current recommendations on including relevant information in labeling for oncology drugs approved for use in combination drug regimens, including important consideration for cross labeling of the drugs. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-11-20/pdf/2020-25737.pdf?ref=fdaweb.com).